SCHEMBL5156487

SCHEMBL5156487

CC(C)c1ccccc1-c1ccc2[nH]c(CCc3ccc(Cl)cc3)nc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.46
TRPV1 Q8NER1 4/20 0.43
RAB9A P51151 5/20 0.43
NPC1 O15118 2/20 0.43
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41
TUBB8 Q3ZCM7 1/20 0.41
TUBA3E Q6PEY2 1/20 0.41
TUBA1A Q71U36 1/20 0.41
TUBA1C Q9BQE3 1/20 0.41
TUBB6 Q9BUF5 1/20 0.41
TUBB2B Q9BVA1 1/20 0.41
TUBB1 Q9H4B7 1/20 0.41
NTRK1 P04629 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1798998 0.92 TRPV1 (0.44) TRPV1RAB9ANPC1TUBB4ATUBB
SCHEMBL5152122 0.89 RAB9A (0.45) TRPA1TRPV1RAB9ANPC1TUBB4A
SCHEMBL2241134 0.81 RAB9A (0.55) RAB9ANPC1TUBB4ATUBBTUBA3C
SCHEMBL1799573 0.81 RAB9A (0.43) TRPA1TRPV1RAB9ANPC1TUBB4A
SCHEMBL1798966 0.81 TRPV1 (0.66) TRPV1RAB9ANPC1TUBB4ATUBB
SCHEMBL2239031 0.81 BRS3 (0.49) TRPV1RAB9ANPC1TUBB4ATUBB
SCHEMBL12359239 0.80 BRS3 (0.48) TRPV1RAB9ANPC1TUBB4ATUBB
SCHEMBL8595978 0.80 RAB9A (0.45) RAB9ANPC1TUBB4ATUBBTUBA3C
SCHEMBL2240825 0.79 TRPV1 (0.55) TRPV1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1798653 0.79 TRPV1 (0.65) TRPV1RAB9ANPC1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259936-A1 Benzimidazole Modulators of VR1 JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259936-A1 Benzimidazole Modulators of VR1 VRK1, VRK2, VIL1 TRPA1 251/4885TRPV1 29/4885RAB9A 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.